Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apellis Pharmaceuticals
Pharma
Apellis stock price slid 10% despite 'robust' growth of Syfovre
Despite the expansion of Syfovre in geographic atrophy ahead of analysts' expectations, Apellis' stock price has dropped 30% so far this year.
Angus Liu
May 8, 2024 11:30am
Apellis working through continued challenges with Syfovre launch
Feb 28, 2024 11:53am
Bristol Myers wins, Apellis loses in busy week at Europe's CHMP
Jan 26, 2024 11:36am
JPM24, Day 1: BMS, Amgen, Regeneron and more
Jan 8, 2024 4:18pm
AstraZeneca, Takeda, BioNTech—Fierce Pharma Asia
Nov 10, 2023 8:05am
Apellis counters Izervay results with long-term data of its own
Nov 6, 2023 3:53pm